Home > Healthcare > Pharmaceuticals > Finished Drug Form > Viscosupplementation Market

Viscosupplementation Market Trends

Report ID: GMI4212
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Viscosupplementation Market Trends

Technological improvements have impacted many aspects of healthcare, including viscosupplementation, over the years. The ongoing efforts toward developing more sophisticated and effective hyaluronic acid formulations for viscosupplementation and the advent of specialized injection devices and instruments that allow accurate and exact medicine delivery has increased product uptake. The market outlook is expected to strengthen as these breakthroughs continue to emerge, providing new opportunities for the innovation of improved treatment that results and better management of joint-related disorders.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for viscosupplementation generated USD 3.6 billion in 2022 and is projected to grow at over a 9% CAGR from 2023 to 2032 attributed to the increasing prevalence of osteoarthritis among the geriatric population.

Single injection segment reached around USD 1.4 billion in 2022, attributed to the growing patient preference for single injection viscosupplementation technique.

The North America viscosupplementation market is set to amass around USD 3.4 billion by 2032, driven by the rising prevalence of arthritis and other bone-related disorders across the region.

The global viscosupplementation industry includes major companies such as Zimmer Biomet OrthogenRX, Anika Therapeutics, Inc., and Bioventus, among others.